The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 901–1,000 of 1,810
Maternal exposure to pesticides and gestational diabetes mellitus in the Elfe cohort
Guesdon, L., Warembourg, C., Chevrier, C., de Lauzon‐Guillain, B., Caudeville, J., Charles, M.-A. A., Lous, M. L., Blanc‐Petitjean, P., & Béranger, R. (2025) · Environmental Research · doi:10.1016/j.envres.2025.122275 · Cited by 6
Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy
Basri, N. I., Murthi, P., & Rahman, R. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179681 · Cited by 4
“Obesity is characterized by chronic inflammation of adipose tissue, which is the key player in the development of T2D and GDM [4].”
BackgroundInfluentialRenugasundari, M., Pal, G. K., Chaturvedula, L., Nanda, N., Harichandrakumar, H. K., & Vidyalakshmi, L. (2021) · International Journal of Clinical and Experimental Physiology · doi:10.5530/ijcep.2021.8.1.5 · Cited by 4
“As insulin promotes the entry of glucose uptake into cells through GLUT4, insulin resistance prevents entry of glucose into cells.[8,9] This results in hyperglycemia which mimics T2DM.”
BackgroundEarly gestational diabetes mellitus: An update about its current status
Mohan, V., Hannah, W., & Anjana, R. M. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01370-0 · Cited by 6
Xu, J., Wu, Y., Zou, Z., & Chen, X. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191710726 · Cited by 4
“These adverse effects include pre-eclampsia, cesarean delivery, and later development of type 2 diabetes in women with GDM [4,5], as well as macrosomia, perinatal mortality, and higher living risk of obesity and type 2 diabetes in offspring born to mothers with GDM [4,6].”
BackgroundImpact of Selected Eicosanoids in Normal and Pathological Pregnancies
Szczuko, M., Golańska, J., Palma, J., & Ziętek, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185995 · Cited by 7
“It is recognized that gestational diabetes mellitus is a temporary glucose intolerance caused by failure of the pancreas to secrete insulin by beta cells and insulin resistance of tissues such as subcutaneous, muscle, and liver tissues [12,13].”
BackgroundDeng, Y., Xu, C., Yang, A., Wang, Y., Peng, Y., Zhou, Y., Luo, X., Wu, Y., & Zhong, S. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06602-z · Cited by 5
“Risk factors for GDM include obesity, advanced maternal age, GDM in a previous pregnancy, and a family history of diabetes [5, 6].”
BackgroundZhou, X., Wei, L., Li, J., Zhang, J., Zhu, S., Zhang, H., Jia, J., Yu, J. J., Wang, S., & Feng, L. (2020) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000044 · Cited by 5
Fisioterapia no Cuidado ao Sistema Familiar: Uma Abordagem à Pessoa Idosa Fragilizada
Valença, T. D. C., & da Silva, L. W. S. (2011) · Americanae (AECID Library) · doi:10.23925/2176-901x.2011v14iespecial9p89-104 · Cited by 7
Lesniara-Stachon, A., Quansah, D. Y., Schenk, S., Retsa, C., Halter, R. J., Murray, M. M., Lacroix, A., Horsch, A., Toepel, U., & Puder, J. J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067013 · Cited by 5
Sirtuins and Their Implications in the Physiopathology of Gestational Diabetes Mellitus
Zgutka, K., Tkacz, M., Grabowska, M., Mikołajek-Bedner, W., & Tarnowski, M. (2025) · Pharmaceuticals · doi:10.3390/ph18010041 · Cited by 5
“…of gestation, a history of GDM, advanced maternal age (AMA), a family history of IR and diabetes, obesity (pre-pregnancy body mass index [BMI] ≥ 30 kg/m 2 ), pre-pregnancy polycystic ovary syndrome, prior delivery of a newborn more than 4000 g in weight, multi-parity, and ethnicity [1,2,4,9,11,12].”
Harmonised Methods for Detection of Insulin Immunogenicity
Sathiya, V., & Kumar, V. (2024) · International Journal of Pharmaceutical Investigation · doi:10.5530/ijpi.14.2.38 · Cited by 4
Evaluation of Nrg4 and thiol/disulfide homeostasis in patients with GDM
CİNDOĞLU, Ç., Uyanıkoğlu, H., Esercan, A., Eren, M. A., Koyuncu, İ., & Sabuncu, T. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.04.011 · Cited by 6
Chen, N., Zeng, R., Xu, C., Lai, F., Chen, L., Wang, C., Pei, L., Li, Z., Li, Y., Xiao, H., et al. (2023) · Nutrients · doi:10.3390/nu15092193 · Cited by 7
“GDM develops when a woman’s pancreas fails to secrete enough insulin in response to significantly decreased insulin sensitivity, resulting in varying degrees of hyperglycemia [5].”
BackgroundÖren, E. D. T., Avdal, E. Ü., Polat, G., Sofulu, F., Düzgün, G., & Pamuk, G. (2024) · Medicine · doi:10.1097/md.0000000000037755 · Cited by 5
Zeng, Y., Meng, X., Wen, M., Qin, Y., Wang, X., Dai, X., & Huang, Q. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5109209 · Cited by 4
Ansari‐Lari, M., Kazemipour, N., Yaghoobi, E., & Masoudian, M. (2024) · Acta Tropica · doi:10.1016/j.actatropica.2024.107204 · Cited by 5
Diagnosis of gestational diabetes: Evidence and pitfalls
Wong, T., Immanuel, J., Wong, V. W., Barnes, R., & Simmons, D. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102069 · Cited by 4
Zhang, L. (2021) · Archives of Medical Science · doi:10.5114/aoms/136284 · Cited by 8
“2 Arch Med Sci disorders, fetal malformation, polyhydramnios, spontaneous abortion, fetal distress, stillbirth, ketoacidosis, neonatal hypoglycemia, hypocalcemia, hyperbilirubinemia, and postpartum development of type 2 diabetes [2-5].”
BackgroundSzlapinski, S. K., & Hill, D. J. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0317 · Cited by 6
Trejo-González, N. L., Palomar-Morales, M., Baiza-Gutman, L. A., Díaz-Rosas, G., Ortega‐Camarillo, C., & Contreras‐Ramos, A. (2025) · Metabolites · doi:10.3390/metabo15060367 · Cited by 6
“Furthermore, children born to diabetic mothers are at an elevated risk of developing type 2 diabetes (T2D), obesity, dyslipidemia, and other related conditions [3,4].”
Preston, E. V., Quinn, M. R., Williams, P. L., McElrath, T. F., Cantonwine, D. E., Seely, E. W., Wylie, B. J., Hacker, M. R., O'Brien, K., Brown, F. M., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079782 · Cited by 5
Wafa, M. H., Ayoub, A. I., Bukhari, T. A., Bugnah, A. A. A., Alabawy, A. A. H., Alsaiari, A. H., Aljondi, H. M., Alhusseini, S. H., Alenazi, F. A., & Refai, H. M. (2023) · Cureus · doi:10.7759/cureus.48151 · Cited by 10
“…like a second-trimester miscarriage, preterm birth, preeclampsia, cesarean section, macrosomia to shoulder dystocia, trauma during delivery, stillbirth, neonatal hyperbilirubinemia, hypoglycemia, hypocalcemia, polycythemia, respiratory distress syndrome, and hypertrophic cardiomyopathy [10,11].”
BackgroundQuan, F., Gao, C., Magnuson, J. T., Yu, L. J., Qiu, W., Xuan, R., Lu, H., & Zheng, Y. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.140890 · Cited by 9
Zade, S. R., Khasbage, S. U., Mishra, A., & Mehani, R. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101442 · Cited by 9
Narindrarangkura, P., Alafaireet, P. E., Khan, U., & Kim, M. S. (2023) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174231162477 · Cited by 5
“We excluded gestational diabetes because the pathophysiology of gestational diabetes is different from T1DM and T2DM.23 Also, the physiology of pregnant women changes throughout the pregnancy.24 The second objective of the literature review was to identify risk factors for depression among people with diabetes (Figure…”
BackgroundLow serum level of irisin and gestational diabetes mellitus
Li, Y., Kuo, T., & Wang, P. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.05.001 · Cited by 4
Pi, Z., Chen, Y., Nie, Z., Peng, J., & Jiang, Z. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2224489 · Cited by 4
“Overweight and obesity affect insulin signaling pathways and have been associated with inflammation, insulin resistance, and oxidative stress [41,42].”
BackgroundMusa, O. A. H., Islam, N., Thalib, L., & Doi, S. A. R. (2019) · Obesity Reviews · doi:10.1111/obr.12913 · Cited by 4
“β‐cell dysfunction is exacerbated by hyperglycemia, and the direct influence of glucose to β‐cell failure is described as glucotoxicity.(3) Thus, once β‐cell dysfunction starts, a vicious cycle of hyperglycemia, insulin resistance, and further β‐cell dysfunction is set in motion.”
BackgroundResultInfluentialImpairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitus
Zhang, D., Zhu, J., Albrechtsen, N. J. W., Rayner, C. K., Saffery, R., Zhang, H., Chen, C., & Wu, T. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15740 · Cited by 4
“In keeping with the concept of insulin resistance and insufficient compensation of beta-cell function as the nexus of these derangements, 22 both fasting insulin and HOMA-IR were higher and HOMA-β lower in GDM than CON participants in the present study.”
Assessment of autism-relevant behaviors in C57BKS/J leptin receptor deficient mice
Greene, S. M., Sanchez, Y. R., Pathapati, N., Davis, G. N., & Gould, G. G. (2021) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104919 · Cited by 5
Sfameni, S. F., Wein, P., & Sfameni, A. M. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15074 · Cited by 5
“20 Evaluating islet β - cell insulin stores in early pregnancy with the 75-g 1-h GCT allows the clinician to undertake a risk assessment for the diagnosis of GD and gestational hyperglycemia in late pregnancy.”
MethodBandeira, D. B., Santos, G. D. A., Glezer, A., Machado, M. C., Boguszewski, C. L., & Nogueira, V. D. S. N. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10016-x · Cited by 5
Jung, A. R., Seo, Y., Lee, J., Hwang, J. G., Yun, S., & Lee, D. T. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175004 · Cited by 4
“Exercise may positively impact all these aspects, not just blood glucose management [11].”
BackgroundBellach, L., Gard, L.-I., Lindner, S. D., Baumgartner-Parzer, S. M., Klimek, P., Kautzky‐Willer, A., & Leutner, M. (2023) · Nutrients · doi:10.3390/nu15112498 · Cited by 3
“Another potential risk factor GDM might pose is the dysbalances in adipokine levels (hormones derived from the adipose tissue which has, next to energy storing and insulating properties, also endocrine functions [8]).”
BackgroundAlternative Polyadenylation Results in mRNA Transcript Instability in Gestational Diabetes Mellitus
He, Y., & Wu, N. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s400283 · Cited by 4
“In the long term, infants born with GDM pregnancy are at increased risk of obesity, T2DM, CVD and related metabolic diseases.(6) When the RNA chain extends to the TTS site, the RNA polymerase will no longer form a new phosphodiester bond, the RNA DNA hybrid will be separated, the transcription bubble will collapse, an…”
BackgroundInfluentialTang, X., Wei, J., Wu, S., & Wu, S. (2024) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17897 · Cited by 4
“4 The study's data on FBG levels during early, middle, and late pregnancy align with the expected trend of a decrease followed by an increase.”
MANAGEMENT OF GESTASIONAL DIABETES MELLITUS IN A BETA MAJOR THALASSEMIA PATIENT
Fonda, T., & Novida, H. (2021) · Current Internal Medicine Research and Practice Surabaya Journal · doi:10.20473/cimrj.v2i2.26255 · Cited by 4
The Association between Vitamin D Intake and Gestational Diabetes Mellitus: A Systematic Review
Kokkinari, A., Dagla, M., Lykeridou, A., & Iatrakis, G. M. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5005096 · Cited by 4
“In most cases, hyperglycemia is the result of reduced glucose tolerance, due to dysfunction of pancreatic beta cells, against the background of chronic insulin resistance [19].”
BackgroundInfluentialLi, N., Leng, J., Zhang, R., Wang, H., Li, W., Zhang, S., Qiao, Y., Li, J., Yu, Z., Hu, G., et al. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002967 · Cited by 4
“[8] They could contribute to the accumulation of adipose tissues and protein in the fetus, leading to a vicious intergenerational cycle of obesity.”
Xu, M., Ye, X., Cai, F., & Wu, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1526714 · Cited by 3
“These findings indicate that approximately 1 in 5–6 pregnant women is diagnosed with GDM (Plows et al., 2018).”
Paneth Cell, Gut Microbiota Dysbiosis and Diabetes Mellitus
Luvhengo, T. E., Mabasa, S., Molepo, E., Taunyane, I., & Palweni, S. T. (2023) · Applied Sciences · doi:10.3390/app13116605 · Cited by 3
Versace, V. L., Boyle, D. I., Janus, E. D., Dunbar, J., Feyissa, T. R., Belsti, Y., Trinder, P., Enticott, J., Sutton, B. A., Speight, J., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-106052 · Cited by 4
Lin, L., Chen, R., Lin, H., Yao, T. S., Chen, Z., & Zheng, L. (2024) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.41.1.11412 · Cited by 4
Zhao, C., Liu, H., Deng, Y., Wu, H., Wang, S., Lyu, X., Lei, J., Yang, H., Hu, M., Zhao, Y., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111111 · Cited by 3
Mshelia, D. S., Adamu, S., & Gali, R. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96549 · Cited by 6
Jahromi, H. K., Ghasemi, F., & Mikaeiliagah, E. (2024) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_47_23 · Cited by 3
Nose-to-brain delivery of insulin nanoparticles for diabetes management: A review
Kumbhare, M. R., Surana, A. R., & Morankar, P. (2023) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v4i01.178 · Cited by 4
“15 Various carriers, such as macromolecules and liposomes, are used for in vivo drug delivery.”
Gestational diabetes: from pathogenesis to therapeutic intervention
Zhang, X., Chi, Y., Zhang, Z., Wang, Y., Yi, F., Wang, P., Liu, Y., & Hao, W. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02156-6 · Cited by 3
Xi, Y., Wu, Q., Yin, B., Zhang, J., & Bai, Y. (2025) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.70016 · Cited by 3
“44 The resulting fetal hyperinsulinemia decreases fetal glucose levels, thereby increasing the glucose concentration gradient across the placenta and promoting glucose flux to the fetus.”
The role of hsa_circ_0042260/ miR ‐4782‐3p/ LAPTM4A axis in gestational diabetes mellitus
Ji, R. P., Yang, H., Chen, J., Zhao, A., Chen, X., & Niu, Y. (2024) · Apmis · doi:10.1111/apm.13407 · Cited by 3
“The pathogenesis of GDM is multifaceted, involving factors such as genetics, insulin resistance, and placental lactogen production [6].”
BackgroundNwachukwu, E. U., Ezeamii, J. C., Okoye, T. O., Okobi, O. E., Ojo, R. O., Akinsola, Z., Gebeyehu, Y. H., & Osarenkhoe-Ighodaro, E. A. (2023) · Cureus · doi:10.7759/cureus.49694 · Cited by 4
Huang, B., & Zhai, H. (2024) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2024.2435065 · Cited by 6
“However, noting that insulin resistance may limit the effectiveness of this treatment is crucial (Plows et al. 2018, Mcintyre et al. 2019).”
Early- to mid-gestational testosterone excess leads to adverse cardiac outcomes in postpartum sheep
Alkhatib, B., Ciarelli, J. N., Ghnenis, A. B., Pallas, B. D., Olivier, N. B., Padmanabhan, V., & Vyas, A. K. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00763.2023 · Cited by 4
Unveiling the role of microRNAs in metabolic dysregulation of Gestational Diabetes Mellitus
He, L., Wang, X., & Chen, X. (2024) · Reproductive Biology · doi:10.1016/j.repbio.2024.100924 · Cited by 4
França, D. C. H., França, E. L., Honório‐França, A. C., Silva, K. M. R., de Queiroz, A. A., Morais, T. C., França, E. C. H., de Carvalho, C. N. F., Fagundes-Triches, D. L. G., Barbosa, A. M. P., et al. (2025) · Metabolites · doi:10.3390/metabo15110699 · Cited by 6
“Women in the GDM-UI group had the highest BMI between 24 and 28 weeks of gestation, supporting the possibility that these women may be more likely to develop GDM-associated urinary incontinence due to increased weight, compared with women with normal or overweight BMI [29].”
Alwash, S. M., McIntyre, D. H., Najman, J. M., & Mamun, A. A. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.12.005 · Cited by 3
The association of in-utero exposure to air pollution and atherogenic index of plasma in newborns
Seidkhani‐Nahal, A., Heydari, H., Tavakolian, A., Najafi, M. L., & Miri, M. (2024) · Environmental Health · doi:10.1186/s12940-024-01059-1 · Cited by 4
Mercado-Evans, V., Mejia, M. E., Zulk, J. J., Ottinger, S., Hameed, Z., Serchejian, C., Marunde, M. G., Robertson, C. M., Ballard, M. B., Korotkova, N., et al. (2023) · doi:10.1101/2023.06.23.546252 · Cited by 40
Daniele, C., Farland, L. V., Park, K. E., Schnatz, P. F., Shadyab, A. H., Stefanick, M. L., Wactawski‐Wende, J., Wild, R. A., & Spracklen, C. N. (2023) · Early Human Development · doi:10.1016/j.earlhumdev.2023.105839 · Cited by 3
Tang, X., Wei, J., Jiang, Z., & Wu, S. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07298-w · Cited by 3
“Hormonal changes in the body and placenta of pregnant women, such as estrogen, cortisol and placental prolactin, jointly promote the development of insulin resistance [6].”
Huang, P., Deng, Y., Feng, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-761354/v1 · Cited by 3
Ashraf, S., Sadaf, M., Farkhanda, T., Yousaf, S., Iftikhar, A., & Iftikhar, M. (2023) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v26i4.2010 · Cited by 3
Zhao, X., Li, N., Jia, R., Chen, S., & Wang, L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251024 · Cited by 6
“5% of pregnancies worldwide, and the prevalence is rising and correlates with the increase in maternal obesity over recent decades [1].”
BackgroundPastor, F. M., Ocarino, N. M., Silva, J. F., Reis, A. M. S., & Serákides, R. (2024) · Bone · doi:10.1016/j.bone.2024.117169 · Cited by 5
Sütçü, H., Varol, F. G., İnan, C., et al. (2021) · Gynecology Obstetrics and Reproductive Medicine · doi:10.21613/gorm.2021.1177 · Cited by 3
Xie, J., Le, H., & Qin, S. (2025) · Hypertension in Pregnancy · doi:10.1080/10641955.2025.2475814 · Cited by 3
“The reported prevalence of GDM varies between 1% and 14% worldwide and has shown a noticeable increase in recent years (2).”
Iman, A. E. H., Onel, C., Furău, G. O., Furau, C. G., Furau, R., Lucan, M., Şandor, M. I., Sachelarie, L., & Huniadi, A. C. (2025) · Diagnostics · doi:10.3390/diagnostics15131704 · Cited by 7
“Numerous studies have associated GDM with increased long-term risk of type 2 diabetes and cardiometabolic disease in mothers [29,30], as well as adverse fetal programming effects that predispose offspring to obesity and insulin resistance later in life [6,31].”
Gut microbiota and metabolomic alterations in newborns of mothers with gestational diabetes mellitus
Su, W.-H., Wang, Y., Chen, C., Lai, M., Chao, H., Chiang, M., Fu, R.-H., & Yeh, P. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2025.01074 · Cited by 4
Maloney, A. C., Barnas, J., Clart, L., Vieira‐Potter, V. J., & Kanaley, J. A. (2025) · Journal of Endocrinology · doi:10.1530/joe-25-0043 · Cited by 3
Tekin, S., Öçal, A., Güleroğlu, F. Y., Selcuk, C. G. O., Eyisoy, Ö. G., Ocal, E. U. B., & Çetin, A. (2025) · Journal of Clinical Ultrasound · doi:10.1002/jcu.24100 · Cited by 3
Vitronectin stimulates hepatic gluconeogenesis by activating the cAMP/PKA/CREB axis in the liver
Ju, Y., Wu, R., Wang, G., Shen, T., Hu, J., & Kong, Y. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112485 · Cited by 4
Recurrent gestational diabetes: Breaking the transgenerational cycle with lifestyle modification
Liney, T. E. J., Shah, N. M., & Singh, N. (2022) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02004-3 · Cited by 4
“Gestational diabetes mellitus (GDM) is a state of glucose intolerance diagnosed during pregnancy and occurs secondary to pancreatic β-cell dysfunction and insulin resistance during pregnancy [1].”
BackgroundTakemoto, A., Nagai, Y., Kawanabe, S., Nakagawa, T., Matsumoto, K., Hasegawa, J., Suzuki, N., Tanaka, Y., & Sone, M. (2023) · Diabetology International · doi:10.1007/s13340-023-00646-w · Cited by 5
“In healthy pregnant women, hypertrophy or hyperplasia of maternal pancreatic β cells is known to occur to compensate for insulin resistance [12–14].”
BackgroundZhang, X., Rehemutula, R., Jin, H., Teng, Y., Ma, J., Mei, S., Long, Y., Zhao, X., Zeng, F., Huang, Y., et al. (2023) · The Journal of Perinatal & Neonatal Nursing · doi:10.1097/jpn.0000000000000723 · Cited by 5
“22,23 Neonates born to pregnant people with GDM were prone to develop glucose intolerance in the future as shown in the study by Dabelea et al, 24 contributing to a vicious circle of NH.”
BackgroundOsei‐Safo, E. K., Lim, S. S., Makama, M., Chen, M., Skouteris, H., Taylor, F., Harrison, C. L., Hutchesson, M., Bennett, C., Teede, H. J., et al. (2024) · Women s Health · doi:10.1177/17455057241247748 · Cited by 5
Tian, M.-L., Jin, Y., Du, L.-Y., Zhou, G.-Y., Zhang, C., Ma, G.-J., & Shi, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1343172 · Cited by 5
“The etiology of GDM was complicated and this hyperglycemia is the result of impaired glucose tolerance due to pancreatic b -cell dysfunction on a background of chronic insulin resistance (13).”
BackgroundBisphenol S and female reproductive toxicity: a scoping review of human studies
Andrews, F. V., Delker, E., Paul, J. C., Moran, F. M., & Sandy, M. S. (2026) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-026-00868-5 · Cited by 5
Kök, Z., Sıncer, İ., Güneş, Y., & Ural, Ü. M. (2022) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-022-01136-6 · Cited by 4
“However, there is a wealth of evidence for the development of DM later in life in women with a history of GDM [15].”
Backgroundγδ T cells in diabetes mellitus: dual roles and therapeutic implications
Wang, B., Li, Q., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1693466 · Cited by 4
Mapping Lifestyle Interventions for Gestational Diabetes Prevention: A Scoping Review
Peña, A., Miller, A. M., Campbell, A. G., Holden, R. J., & Scifres, C. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01535-5 · Cited by 2
“Leptin, a hormone associated with gestational diabetes and obesity [43], was measured in one study [23].”
Exosomes and their possible applications in the management of gestational diabetes
Sibiak, R., Jaworski, M., Barrett, S., Bryl, R., Gutaj, P., & Wender-Ożegowska, E. (2020) · Medical Journal of Cell Biology · doi:10.2478/acb-2020-0018 · Cited by 4
Rydosz, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99887-1.00001-7 · Cited by 4
Diabetes mellitus and pregnancy (literature review)
Sibirskaya, E. V., & Blinnikova, E. S. (2020) · Russian Journal of Human Reproduction · doi:10.17116/repro202026061122 · Cited by 5
Vasavada, A. M., & Taub, L. M. (2020) · StatPearls · Cited by 7
Exploring abnormal glucose metabolism in pregnancy among Australian Chinese migrants
Li, L., Zhang, J., Shub, A., Aris, I. M., & Tan, K. H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000903 · Cited by 4
Rouholamin, S., Razavi, M., Pirjani, R., & Rezaeinejad, M. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.110982 · Cited by 5
Metformin versus insulin in gestational diabetes mellitus: a systematic review
Berti, G. N., Garcia, I. G. O., de Toledo, J. P. R. F., Tatemoto, J. R., Marino, L. W., Legori, M. D. M., & Toledo, S. F. (2024) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2024rbgo89 · Cited by 6
Downregulation of SLC16A11 is Present in Offspring of Mothers with Gestational Diabetes
Sevilla-Domingo, M., Olivo-Ramirez, C. G., Huerta-Padilla, V. M., Gómez-Díaz, R. A., González-Carranza, E., Acevedo-Rodríguez, G. E., Hernandez-Zuñiga, V. E., Gonzalez, A. L. V., Mateos-Sánchez, L., Mondragón-González, R., et al. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.07.002 · Cited by 3
Liu, C., Wei, C., Yu-lan, L., Chai, F., Wang, C., Zeng, Y., & Huang, H. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1600756 · Cited by 3
Hyperglycemia First Detected in Pregnancy in South Africa: Facts, Gaps, and Opportunities
Coetzee, A., Hall, D. R., & Conradie, M. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.895743 · Cited by 6
“Hyperglycemia in GDM occurs when an adequate increase in insulin secretion does not accompany the IR (13).”
BackgroundInfluentialAssessing Knowledge on Gestational Diabetes Mellitus and Child Health
Ludowici, E. (2023) · Hawai‘i Journal of Health & Social Welfare · doi:10.62547/jgsi6115 · Cited by 7
Ramalho, D., Correia, S., Realista, R., Rocha, G., Alves, H., Almeida, L., Ferreira, E., Monteiro, S., Oliveira, M. J., Almeida, M. C., et al. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01931-x · Cited by 3
“This leads to higher risk of hyperglycemia and decompensation of GD, which is a direct indication for cesarean section [19, 20].”
BackgroundHuang, Y., Liang, B., Yu, N., et al. (2025) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-025-05416-9 · Cited by 3
“The escalating incidence of GDM is closely associated with the global rise in obesity prevalence, sedentary lifestyles, and advanced maternal age [2].”
Sapantzoglou, I., Giourga, M., Kontopoulou, A. M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226637 · Cited by 3
van Hoorn, E. G. M., van Dijk, P. R., Prins, J. R., Lutgers, H. L., Hoogenberg, K., Erwich, J. J., & Kooy, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056282 · Cited by 4
Valencia-Martínez, A., Schaefer-Graf, U. M., Amusquivar, E., Herrera, E., & Ortega, H. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac414 · Cited by 3
Luo, L., Zhu, S., Akbari, A., & Tan, B. (2022) · Natural Product Communications · doi:10.1177/1934578x221141276 · Cited by 5
“11–13 The activation of WNT/β-catenin signaling can increase a cell’s insulin sensitivity by increasing glucose uptake from the bloodstream.(3) However, impairments in the WNT signaling pathways can evolve into the pathogenesis of type 2 diabetes and affect insulin signaling in its target cells, in part due to a decre…”
BackgroundInfluentialNanotechnology Based Topical Insulin Delivery System: Promising Role in Diabetic Wound Healing
Singh, L., Bhakuni, A., Monika, M., Singh, R. P., Arora, S., & Jhawat, V. (2025) · Wound Repair and Regeneration · doi:10.1111/wrr.70087 · Cited by 5
Zawiejska, A., Bogacz, A., Iciek, R., Lewicka-Rabska, A., Brązert, M., Mikołajczak, P. Ł., & Brązert, J. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01799-3 · Cited by 4
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.